• Title/Summary/Keyword: masitinib mesylate

Search Result 1, Processing Time 0.015 seconds

Successful Postoperative Management of Gastrointestinal Stromal Tumor in a Dog

  • Lee, Ki-Sung;Kim, Keon;Yang, Chul-Ho;Suh, Guk-Hyun;Lee, Chang-Min
    • Journal of Veterinary Clinics
    • /
    • v.38 no.4
    • /
    • pp.184-188
    • /
    • 2021
  • A 10-year-old spayed female Maltese with a history of vomiting and lethargy was referred to the hospital. Physical examination revealed dehydration and severe pain following abdominal palpation. A large mass was observed in the cranial abdomen through radiography and ultrasonography. Laparotomy was performed to find the origin of the mass. The mass was about 8 cm originating from the cecum and subsequently removed. Histopathologic evaluation revealed that the cecal mass was suspected to be a mesenchymal-derived tumor. Through immunohistochemistry, the mass was diagnosed as a gastrointestinal stromal tumor (GIST) based on the c-kit expression. Given its recurrence, postoperative preventive therapy was initiated with masitinib mesylate, which is a tyrosine kinase inhibitor. The animal did not show any side effects during the medication period. After 6 months of therapy, it was well controlled without any recurrence. In this case, we introduced a novel postoperative management of GIST using masitinib mesylate.